Harrison Linder, MD
Interventional Pain Medicine · Baltimore, MDNPI 1245596139
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Nevro Corp. at 29.9% of the total. Reporting peaked in 2022 at $435 and has fallen 60.7% since, to $171 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MD, where the typical reported total is $3,506.
Across 46 payments — averaging $31.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$431
- Boston Scientific$234
- Abbott$167
- Stimwave Technologies Incorporated$153
- Globus Medical$149
- Pfizer$46
- plus $261 from 11 others
What the payments were for
- Food & beverage$1,440100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 10 | $431 |
| Boston Scientific | 9 | $234 |
| Abbott | 7 | $167 |
| Stimwave Technologies Incorporated | 2 | $153 |
| Globus Medical | 2 | $149 |
| Pfizer | 3 | $46 |
| Averitas Pharma Inc. | 2 | $45 |
| IBSA Pharma Inc. | 2 | $35 |
| Si-bone, Inc. | 1 | $29 |
| Acacia Pharma Inc | 1 | $24 |
| Relievant Medsystems, Inc. | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Vertex | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Electronic Waveform Lab, Inc. | 1 | $18 |
| Convatec Inc. | 1 | $18 |
| Avanos Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,440 in reported general payments places this provider in the 15th percentile of 56 interventional pain medicine providers in Maryland.
See all interventional pain medicine providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 526 | $5,476 |
| Baclofen | 447 | $5,345 |
| Pregabalin | 99 | $2,449 |
| Methocarbamol | 42 | $873 |
| Tizanidine Hcl | 56 | $544 |
| Duloxetine Hcl | 13 | $507 |
| Cyclobenzaprine Hcl | 52 | $438 |
| Methylprednisolone | 41 | $313 |
| Meloxicam | 57 | $249 |
| Diclofenac Sodium | 15 | $122 |
| Tramadol Hcl | 13 | $94 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Baltimore
- Dontese NicholsonBaltimore$27K
- Todd RuthBaltimore$20K
- Srinivasa RajaBaltimore$18K
- Bradford WintersBaltimore$4K
- Michael GardynBaltimore$2K
- Eric JacksonBaltimore$2K
- Kayode WilliamsBaltimore$587
- Matthew HansenBaltimore$580
- Mark ColemanPikesville$1.3M
- Marc LoevRockville$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.